Apoptosis in B lymphocytes: The WEHI‐231 perspective

Immunology and Cell Biology

Volumn 73, Issue 1, 1995, Pages 8-16

  GOTTSCHALK, ALEXANDER R ^a   QUINTANS, JOSE ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

apoptosis; B lymphocytes; cell division; ceramide; immunosuppressants; phosphorylation; proto oncogenes; signal transduetion; WEHI 231

Indexed keywords

CERAMIDE; CYCLOSPORIN A; DEXAMETHASONE; LYMPHOCYTE ANTIGEN RECEPTOR; RAPAMYCIN; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; B LYMPHOCYTE; CELL CYCLE PHASE; CELL LINE; MOUSE; NONHUMAN; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; APOPTOSIS; AUTOANTIBODIES; B-LYMPHOCYTES; CERAMIDES; LIPOPOLYSACCHARIDES; MICE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0028959263     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.1995.tb03827.x     Document Type: Review

References (87)

1. Cell death: A new classification separating apoptosis from necrosis
2. Toward an understanding of the molecular mechanisms of physiological cell death
3. Apoptosis: A basic biological phenomenon with wide‐ranging implications in tissue kinetics
4. Apoptosis and programmed cell death in immunity
5. Apoptosis: The biochemistry and molecular biology of programmed cell death
6. Cell death: The significance of apoptosis
7. Glucocorticoid‐induced thymocyte apoptosis is associated with endogenous endonuclease activation
8. Macrophage recognition of cells undergoing programmed cell death (apoptosis)
9. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel ‘charge‐sensitive’ recognition mechanism
10. Anti‐immunoglobulin antibodies induce apoptosis in immature B cell lymphomas
11. Anti‐immunoglobulins induce death by apoptosis in WEHI‐ 231 B lymphoma cells
12. Differential induction of Egr‐1 expression in WEHI‐231 sublines does not correlate with apoptosis
13. Physiological cell death in B lymphocytes. I. Differential susceptibility of WEHI‐231 sublines to anti‐Ig induced physiological cell death and lack of correlation with bcl‐2 expression
14. Endogenous expression of delta on the surface of WEHI‐231. Characterization of its expression and signaling properties
15. Antigen receptor‐induced cell cycle arrest in WEHI‐231 B lymphoma cells depends on the duration of signaling before the G1 phase restriction point
16. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI‐231 B lymphoma cells by anti‐mu
17. Resistance to anti‐IgM‐induced apoptosis in a WEHI‐231 subline is due to deficient accumulation of the killer lipid ceramide
18. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen
19. Functional differences between immunoglobulins M and D expressed on the surface of an immature B‐cell line
20. Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype
21. Control of B‐lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fe‐receptor molecules
22. Stimulation of murine B cells with anti‐Ig antibodies: Dominance of a negative signal mediated by the Fc receptor
23. Cross‐linking of B lymphocyte Fc gamma receptors and membrane immunoglobutin inhibits anti‐immunoglobulin‐induced blasto‐genesis
24. Fc‐dependent inhibition of mouse B cell activation by whole anti‐mu antibodies
25. Activation and proliferation signals in mouse B cells. V. A comparison of the effects of intact (IgG) and F (ab')2 anti‐mu or anti‐delta antibodies
26. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors
27. The B lymphocyte calcium response to anti‐Ig is diminished by membrane immunoglobulin cross‐linkage to the Fc gamma receptor
28. Studies on the induction of apoptosis in WEHI 231 cells by pharmacological agents and lipid mediators. Sphingosine and ceramide induce apoptosis in WEHI 231
29. Growth regulation of the B lymphoma cell line WEHI‐231 by anti‐immunoglobulin, lipo‐polysaccharide, and other bacterial products
30. B‐cell apoptosis induced by antigen receptor crosslinking is blocked by a T‐cell signal through CD40
31. Role of bcl‐2 and IL‐5 in the regulation of anti‐IgM induced growth arrest and apoptosis in immature B cell lines
32. The cytotoxic process of CD4Thl clones
33. + cytotoxic T cells induce apoptosis of APC
34. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: The help of Th1 clones is limited by their cytolytic capacity
35. A 39‐kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
36. The Caenorhabditis elegans genes ced‐3 and ced‐4 act cell autonomously to cause programmed cell death
37. Caenorhabditis elegans gene ced‐9 protects cells from programmed cell death
38. Prevention of programmed cell death in Caenorhabditis elegans by human bcl‐2
39. The C. elegans cell death gene ced‐3 encodes a protein similar to mammalian interleukin‐l beta‐converting enzyme
40. Induction of apoptosis in fibroblasts by IL‐1 beta‐converting enzyme, a mammalian homolog of the C. elegans cell death gene ced‐3
41. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin‐1 beta converting enzyme
42. Differential expression of a zinc finger‐encoding gene in response to positive versus negative signaling through receptor immunoglobulin in murine B lymphocytes
43. Methylation of an immediate‐early inducible gene as a mechanism for B cell tolerance induction
44. Signaling through surface IgM in tolerance‐susceptible immature murine B lymphocytes. De‐velopmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice
45. Role for c‐myc in activation‐induced apoptotic cell death in T cell hybrido‐mas
46. Apoptotic cell death induced by c‐myc is inhibited by bcl‐2
47. Cooperative interaction between c‐myc and bcl‐2 proto‐oncogenes
48. Myc‐mediated apoptosis is blocked by ectopic expression of Bcl‐2
49. Signaling of programmed cell death induction in WEHI‐231 B lymphoma cells
50. Isolation and characterization of a B lymphocyte mutant with altered signal transduction through its antigen receptor
51. Thymocyte apoptosis induced by p53‐dependent and independent pathways
52. P53 is required for radiation‐induced apoptosis in mouse thymocytes
53. P53‐dependent apoptosis modulates the cytotoxicity of anticancer agents
54. Wild‐type p53‐triggered apoptosis is inhibited by bel‐2 in a v‐myc‐induced T‐cell lymphoma line
55. Effect of bcl‐2 on Fas antigen‐mediated cell death
56. Lethal effect of the anti‐Fas antibody in mice
57. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
58. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice
59. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
60. Specific regulation of c‐myc oncogene expression in a murine B‐cell lymphoma
61. Immune regulation of the c‐myc oncogene in a murine B lymphoma
62. Egr‐1 mRNA expression is independent of regulatory proliferative responses in the immature B cell line WEHI‐231
63. Lymphoma models for B cell activation and tolerance. X. Anti‐mu‐mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc
64. Mutational analysis of antigen receptor regulation of B lymphocyte growth. Evidence for involvement of the phosphoinositide signaling pathway
65. Bcl‐x, a bcl‐2‐related gene that functions as a dominant regulator of apoptotic cell death
66. Bcl‐2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
67. Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis
68. Bcl‐2 functions in an antioxidant pathway to prevent apoptosis
69. Bcl‐2 inhibition of neural death: Decreased generation of reactive oxygen species
70. Programmed cell death by bcl‐2‐dependent and independent mechanisms in B lymphoma cells
71. Differential effects of the immunosuppressive macrolides FK‐506 and rapamycin on activation‐induced T‐cell apoptosis
72. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin
73. Cyclosporin A inhibits activation‐induced cell death in T cell hybridomas and thymocytes
74. Cyclosporin A, FK‐ 506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction
75. Identification of immunosuppressant‐induced apoptosis in murine B cell lines and its prevention by bcl‐x but not bd‐2
76. Apoptosis in splenic B lymphocytes
77. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma‐interferon. Specific role in cell differentiation
78. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell‐free system by IL‐1 beta
79. Programmed cell death induced by ceramide
80. Selectivity of ceramide‐mediated biology. Lack of activity of erythro‐dihydroceramide
81. Sphingomyelinase and ceramide activate mitogen‐activated protein kinase in myeloid HL‐60 cells
82. Characterization of a ceramide kinase activity from human leukemia (HL‐60) cells. Separation from diacylglycerol kinase activity
83. Ceramide activates heterotrimeric protein phosphatase 2A
84. Ceramide stimulates a cytosolic protein phosphatase
85. Phagocyte recognition of cells undergoing apoptosis
86. Exposure of phos‐phatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages